Create an account to save your articles and sync them across devices
cnbc.com • Finance • World
JPMorgan Chase analyst Chris Schott upgraded Teva Pharmaceuticals stock to overweight due to the company's successful cost-reduction plan, predicting significant margin improvements and future growth.
lemoniteurdespharmacies.fr • Politics • France
French pharmacists express growing concern over their involvement in physician-assisted dying following the National Assembly's vote on a new law.